Copyright Reports & Markets. All rights reserved.

Global and China Viral Vector Development Service Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Viral Vector Development Service Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Retroviral Vectors
    • 1.2.3 Lentiviral Vectors
    • 1.2.4 Adenoviral Vectors
    • 1.2.5 Adeno-associated Viral Vectors
    • 1.2.6 Others Viral Vectors
  • 1.3 Market by Application
    • 1.3.1 Global Viral Vector Development Service Market Share by Application: 2020 VS 2026
    • 1.3.2 Pharmaceutical Manufacturers
    • 1.3.3 Biotechnology Companies
    • 1.3.4 Research Institutes
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Viral Vector Development Service Market Perspective (2015-2026)
  • 2.2 Global Viral Vector Development Service Growth Trends by Regions
    • 2.2.1 Viral Vector Development Service Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Viral Vector Development Service Historic Market Share by Regions (2015-2020)
    • 2.2.3 Viral Vector Development Service Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Viral Vector Development Service Players by Market Size
    • 3.1.1 Global Top Viral Vector Development Service Players by Revenue (2015-2020)
    • 3.1.2 Global Viral Vector Development Service Revenue Market Share by Players (2015-2020)
  • 3.2 Global Viral Vector Development Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Viral Vector Development Service Revenue
  • 3.4 Global Viral Vector Development Service Market Concentration Ratio
    • 3.4.1 Global Viral Vector Development Service Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Viral Vector Development Service Revenue in 2019
  • 3.5 Key Players Viral Vector Development Service Area Served
  • 3.6 Key Players Viral Vector Development Service Product Solution and Service
  • 3.7 Date of Enter into Viral Vector Development Service Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Viral Vector Development Service Breakdown Data by Type (2015-2026)

  • 4.1 Global Viral Vector Development Service Historic Market Size by Type (2015-2020)
  • 4.2 Global Viral Vector Development Service Forecasted Market Size by Type (2021-2026)

5 Viral Vector Development Service Breakdown Data by Application (2015-2026)

  • 5.1 Global Viral Vector Development Service Historic Market Size by Application (2015-2020)
  • 5.2 Global Viral Vector Development Service Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Viral Vector Development Service Market Size (2015-2026)
  • 6.2 North America Viral Vector Development Service Market Size by Type (2015-2020)
  • 6.3 North America Viral Vector Development Service Market Size by Application (2015-2020)
  • 6.4 North America Viral Vector Development Service Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Viral Vector Development Service Market Size (2015-2026)
  • 7.2 Europe Viral Vector Development Service Market Size by Type (2015-2020)
  • 7.3 Europe Viral Vector Development Service Market Size by Application (2015-2020)
  • 7.4 Europe Viral Vector Development Service Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Viral Vector Development Service Market Size (2015-2026)
  • 8.2 China Viral Vector Development Service Market Size by Type (2015-2020)
  • 8.3 China Viral Vector Development Service Market Size by Application (2015-2020)
  • 8.4 China Viral Vector Development Service Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Viral Vector Development Service Market Size (2015-2026)
  • 9.2 Japan Viral Vector Development Service Market Size by Type (2015-2020)
  • 9.3 Japan Viral Vector Development Service Market Size by Application (2015-2020)
  • 9.4 Japan Viral Vector Development Service Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Viral Vector Development Service Market Size (2015-2026)
  • 10.2 Southeast Asia Viral Vector Development Service Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Viral Vector Development Service Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Viral Vector Development Service Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 UJIFILM Diosynth Biotechnologies
    • 11.1.1 UJIFILM Diosynth Biotechnologies Company Details
    • 11.1.2 UJIFILM Diosynth Biotechnologies Business Overview
    • 11.1.3 UJIFILM Diosynth Biotechnologies Viral Vector Development Service Introduction
    • 11.1.4 UJIFILM Diosynth Biotechnologies Revenue in Viral Vector Development Service Business (2015-2020))
    • 11.1.5 UJIFILM Diosynth Biotechnologies Recent Development
  • 11.2 Sanofi
    • 11.2.1 Sanofi Company Details
    • 11.2.2 Sanofi Business Overview
    • 11.2.3 Sanofi Viral Vector Development Service Introduction
    • 11.2.4 Sanofi Revenue in Viral Vector Development Service Business (2015-2020)
    • 11.2.5 Sanofi Recent Development
  • 11.3 Spark Therapeutics
    • 11.3.1 Spark Therapeutics Company Details
    • 11.3.2 Spark Therapeutics Business Overview
    • 11.3.3 Spark Therapeutics Viral Vector Development Service Introduction
    • 11.3.4 Spark Therapeutics Revenue in Viral Vector Development Service Business (2015-2020)
    • 11.3.5 Spark Therapeutics Recent Development
  • 11.4 UniQure
    • 11.4.1 UniQure Company Details
    • 11.4.2 UniQure Business Overview
    • 11.4.3 UniQure Viral Vector Development Service Introduction
    • 11.4.4 UniQure Revenue in Viral Vector Development Service Business (2015-2020)
    • 11.4.5 UniQure Recent Development
  • 11.5 MassBiologics
    • 11.5.1 MassBiologics Company Details
    • 11.5.2 MassBiologics Business Overview
    • 11.5.3 MassBiologics Viral Vector Development Service Introduction
    • 11.5.4 MassBiologics Revenue in Viral Vector Development Service Business (2015-2020)
    • 11.5.5 MassBiologics Recent Development
  • 11.6 FinVector
    • 11.6.1 FinVector Company Details
    • 11.6.2 FinVector Business Overview
    • 11.6.3 FinVector Viral Vector Development Service Introduction
    • 11.6.4 FinVector Revenue in Viral Vector Development Service Business (2015-2020)
    • 11.6.5 FinVector Recent Development
  • 11.7 Thermo Fisher Scientific (Brammer Bio)
    • 11.7.1 Thermo Fisher Scientific (Brammer Bio) Company Details
    • 11.7.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
    • 11.7.3 Thermo Fisher Scientific (Brammer Bio) Viral Vector Development Service Introduction
    • 11.7.4 Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vector Development Service Business (2015-2020)
    • 11.7.5 Thermo Fisher Scientific (Brammer Bio) Recent Development
  • 11.8 Cell and Gene Therapy Catapult
    • 11.8.1 Cell and Gene Therapy Catapult Company Details
    • 11.8.2 Cell and Gene Therapy Catapult Business Overview
    • 11.8.3 Cell and Gene Therapy Catapult Viral Vector Development Service Introduction
    • 11.8.4 Cell and Gene Therapy Catapult Revenue in Viral Vector Development Service Business (2015-2020)
    • 11.8.5 Cell and Gene Therapy Catapult Recent Development
  • 11.9 Cobra Biologics
    • 11.9.1 Cobra Biologics Company Details
    • 11.9.2 Cobra Biologics Business Overview
    • 11.9.3 Cobra Biologics Viral Vector Development Service Introduction
    • 11.9.4 Cobra Biologics Revenue in Viral Vector Development Service Business (2015-2020)
    • 11.9.5 Cobra Biologics Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Viral Vector Development Service Scope and Market Size
    Viral Vector Development Service market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Viral Vector Development Service market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Retroviral Vectors
    Lentiviral Vectors
    Adenoviral Vectors
    Adeno-associated Viral Vectors
    Others Viral Vectors

    Market segment by Application, split into
    Pharmaceutical Manufacturers
    Biotechnology Companies
    Research Institutes

    Based on regional and country-level analysis, the Viral Vector Development Service market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Viral Vector Development Service market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    UJIFILM Diosynth Biotechnologies
    Sanofi
    Spark Therapeutics
    UniQure
    MassBiologics
    FinVector
    Thermo Fisher Scientific (Brammer Bio)
    Cell and Gene Therapy Catapult
    Cobra Biologics

    Buy now